Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma

Journal of Proteome Research

Volumn 12, Issue 12, 2013, Pages 5996-6003

  Lin, De ^a,b   Alborn, William E ^b   Slebos, Robbert J C ^a,b   Liebler, Daniel C ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

biomarker verification; colon cancer; immunoprecipitation; MRM; plasma biomarkers

Indexed keywords

BOVINE SERUM ALBUMIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; ENDOGLIN; GELATINASE B; MESOTHELIN; STABLE ISOTOPE; THROMBOSPONDIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR MARKER; ANTIBODY; CELL SURFACE RECEPTOR; COMP PROTEIN, HUMAN; ENG PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; MMP9 PROTEIN, HUMAN; THROMBOSPONDIN; TIMP1 PROTEIN, HUMAN;

ARTICLE; BLOOD ANALYSIS; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; ISOTOPE DILUTION ASSAY; LIMIT OF DETECTION; MASS SPECTROMETER; MASS SPECTROMETRY; MONITORING; MULTIPLE REACTION MONITORING MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; BLOOD; BOVINAE; CARCINOMA; CHEMISTRY; COLONIC NEOPLASMS; COMPARATIVE STUDY; GENETICS; HERNIA; MOLECULAR GENETICS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, CD; CARCINOMA; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CATTLE; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GPI-LINKED PROTEINS; HERNIA; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; THROMBOSPONDINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 84890101257     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400877e     Document Type: Article

References (33)

1. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: The long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-983
2. Shi, T.; Fillmore, T. L.; Sun, X.; Zhao, R.; Schepmoes, A. A.; Hossain, M.; Xie, F.; Wu, S.; Kim, J. S.; Jones, N.; Moore, R. J.; Pasa-Tolic, L.; Kagan, J.; Rodland, K. D.; Liu, T.; Tang, K.; Camp, D. G., 2nd; Smith, R. D.; Qian, W. J. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (38) 15395-15400
3. Shi, T.; Su, D.; Liu, T.; Tang, K.; Camp, D. G., 2nd; Qian, W. J.; Smith, R. D. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics Proteomics 2012, 12 (8) 1074-1092
4. Zhou, J. Y.; Dann, G. P.; Shi, T.; Wang, L.; Gao, X.; Su, D.; Nicora, C. D.; Shukla, A. K.; Moore, R. J.; Liu, T.; Camp, D. G., 2nd; Smith, R. D.; Qian, W. J. Simple sodium dodecyl sulfate-assisted sample preparation method for LC-MS-based proteomics applications Anal. Chem. 2012, 84 (6) 2862-2867
5. Barnidge, D. R.; Goodmanson, M. K.; Klee, G. G.; Muddiman, D. C. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry J. Proteome Res. 2004, 3 (3) 644-652
6. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-588
7. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-1877
8. Shi, T.; Zhou, J. Y.; Gritsenko, M. A.; Hossain, M.; Camp, D. G., 2nd; Smith, R. D.; Qian, W. J. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery Methods 2012, 56 (2) 246-253
9. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-641
10. Keshishian, H.; Addona, T.; Burgess, M.; Mani, D. R.; Shi, X.; Kuhn, E.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2009, 8 (10) 2339-2349
11. Anderson, N. L.; Anderson, N. G.; Haines, L. R.; Hardie, D. B.; Olafson, R. W.; Pearson, T. W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) J. Proteome Res. 2004, 3 (2) 235-244
12. Kuhn, E.; Addona, T.; Keshishian, H.; Burgess, M.; Mani, D. R.; Lee, R. T.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin. Chem. 2009, 55 (6) 1108-1117
13. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6 (12) 2212-2229
14. Razavi, M.; Frick, L. E.; LaMarr, W. A.; Pope, M. E.; Miller, C. A.; Anderson, N. L.; Pearson, T. W. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry J. Proteome Res. 2012, 11 (12) 5642-5649
15. Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29 (7) 625-634
16. Addona, T. A.; Shi, X.; Keshishian, H.; Mani, D. R.; Burgess, M.; Gillette, M. A.; Clauser, K. R.; Shen, D.; Lewis, G. D.; Farrell, L. A.; Fifer, M. A.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nat. Biotechnol. 2011, 29 (7) 635-643
17. Hoofnagle, A. N.; Becker, J. O.; Wener, M. H.; Heinecke, J. W. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry Clin. Chem. 2008, 54 (11) 1796-104
18. Berna, M.; Ott, L.; Engle, S.; Watson, D.; Solter, P.; Ackermann, B. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: A biomarker of drug-induced cardiac hypertrophy Anal. Chem. 2008, 80 (3) 561-566
19. Berna, M. J.; Zhen, Y.; Watson, D. E.; Hale, J. E.; Ackermann, B. L. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis Anal. Chem. 2007, 79 (11) 4199-4205
20. Nicol, G. R.; Han, M.; Kim, J.; Birse, C. E.; Brand, E.; Nguyen, A.; Mesri, M.; FitzHugh, W.; Kaminker, P.; Moore, P. A.; Ruben, S. M.; He, T. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients Mol. Cell. Proteomics 2008, 7 (10) 1974-1982
21. Wang, Q.; Chaerkady, R.; Wu, J.; Hwang, H. J.; Papadopoulos, N.; Kopelovich, L.; Maitra, A.; Matthaei, H.; Eshleman, J. R.; Hruban, R. H.; Kinzler, K. W.; Pandey, A.; Vogelstein, B. Mutant proteins as cancer-specific biomarkers Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (6) 2444-2449
22. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: An open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-968
23. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
24. Whiteaker, J. R.; Zhao, L.; Abbatiello, S. E.; Burgess, M.; Kuhn, E.; Lin, C.; Pope, M. E.; Razavi, M.; Anderson, N. L.; Pearson, T. W.; Carr, S. A.; Paulovich, A. G. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry Mol. Cell. Proteomics 2011, 10 (4) M110 005645
25. Fusaro, V. A.; Mani, D. R.; Mesirov, J. P.; Carr, S. A. Prediction of high-responding peptides for targeted protein assays by mass spectrometry Nat. Biotechnol. 2009, 27 (2) 190-198
26. Chen, X.; Su, Y.; Fingleton, B.; Acuff, H.; Matrisian, L. M.; Zent, R.; Pozzi, A. Increased plasma MMP9 in integrin α1-null mice enhances lung metastasis of colon carcinoma cells Int. J. Cancer 2005, 116 (1) 52-61
27. Creaney, J.; Francis, R. J.; Dick, I. M.; Musk, A. W.; Robinson, B. W.; Byrne, M. J.; Nowak, A. K. Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burden Clin. Cancer Res. 2011, 17 (5) 1181-1189
28. Hawinkels, L. J.; Kuiper, P.; Wiercinska, E.; Verspaget, H. W.; Liu, Z.; Pardali, E.; Sier, C. F.; ten Dijke, P. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis Cancer Res. 2010, 70 (10) 4141-4150
29. Holten-Andersen, M. N.; Christensen, I. J.; Nielsen, H. J.; Stephens, R. W.; Jensen, V.; Nielsen, O. H.; Sorensen, S.; Overgaard, J.; Lilja, H.; Harris, A.; Murphy, G.; Brunner, N. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer Clin. Cancer Res. 2002, 8 (1) 156-164
30. Jubb, A. M.; Hurwitz, H. I.; Bai, W.; Holmgren, E. B.; Tobin, P.; Guerrero, A. S.; Kabbinavar, F.; Holden, S. N.; Novotny, W. F.; Frantz, G. D.; Hillan, K. J.; Koeppen, H. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer J. Clin. Oncol. 2006, 24 (2) 217-227
31. Klee, E. W.; Bondar, O. P.; Goodmanson, M. K.; Dyer, R. B.; Erdogan, S.; Bergstralh, E. J.; Bergen, H. R., 3rd; Sebo, T. J.; Klee, G. G. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood Clin. Chem. 2012, 58 (3) 599-609
32. Sorensen, N. M.; Bystrom, P.; Christensen, I. J.; Berglund, A.; Nielsen, H. J.; Brunner, N.; Glimelius, B. TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid Clin. Cancer Res. 2007, 13 (14) 4117-4122
33. Whiteaker, J. R.; Zhao, L.; Anderson, L.; Paulovich, A. G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers Mol. Cell. Proteomics 2010, 9 (1) 184-196